HIV/AIDS is an ongoing global pandemic, with an estimated 39 million infected worldwide. Early detection is anticipated to help improve outcomes and prevent further infections. Machine learning (ML) and artificial intelligence (AI) have the potential to improve HIV care by optimizing disease diagnosis, treatment selection, and risk stratification for prevention strategies. The global artificial intelligence (ai) in hiv/aids market is expected to increase by USD 1,480 million, at a compound annual growth rate (CAGR) of 34.7% from 2022 to 2028, according to the latest edition of the Global Artificial Intelligence (AI) in HIV/AIDS Market Report.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global artificial intelligence (ai) in hiv/aids market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the artificial intelligence (ai) in hiv/aids industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the type, application, and region. The global market for artificial intelligence (ai) in hiv/aids can be segmented by type: machine learning (ML), natural language processing (NLP). Artificial intelligence (ai) in hiv/aids market is further segmented by application: diagnosis, health management, research, therapy, others. The therapy segment captured the largest share of the market in 2021. Based on region, the artificial intelligence (ai) in hiv/aids market is segmented into: Asia Pacific, Europe, North America, Rest of the World (RoW).

By type:
– machine learning (ML)
– natural language processing (NLP)

By application:
– diagnosis
– health management
– research
– therapy
– others

By region:
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)

The report also provides a detailed analysis of several leading artificial intelligence (ai) in hiv/aids market vendors that include Enzolytics Inc., Intel Corporation, International Business Machines Corporation (IBM), Johnson & Johnson, Microsoft Corporation, NVIDIA Corporation, Siemens Healthineers AG, among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
– To analyze and forecast the market size of the global artificial intelligence (ai) in hiv/aids market.
– To classify and forecast the global artificial intelligence (ai) in hiv/aids market based on type, application, region.
– To identify drivers and challenges for the global artificial intelligence (ai) in hiv/aids market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global artificial intelligence (ai) in hiv/aids market.
– To identify and analyze the profile of leading players operating in the global artificial intelligence (ai) in hiv/aids market.

Why Choose This Report
– Gain a reliable outlook of the global artificial intelligence (ai) in hiv/aids market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.